![Janice M. Smiell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Janice M. Smiell
Nessuna posizione attualmente
Profilo
Janice M.
Smiell formerly worked at Celgene Corp., as Director-Global Clinical Research & Development from 2003 to 2007, Johnson & Johnson, as Senior Director-Global Clinical Research from 1994 to 2003, AHS Hospital Corp., as Medical Director-Wound Care Center, LifeCell Corp., as Vice President-Medical Affairs from 2007 to 2011, and Alliqua BioMedical, Inc., as Chief Medical Officer from 2014 to 2017.
Dr. Smiell received her graduate degree from Drexel University College of Medicine.
Precedenti posizioni note di Janice M. Smiell
Società | Posizione | Fine |
---|---|---|
Alliqua BioMedical, Inc.
![]() Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Direttore Tecnico/Scientifico/R&S | 01/02/2017 |
LifeCell Corp.
![]() LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
CELGENE | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
JOHNSON & JOHNSON | Direttore Tecnico/Scientifico/R&S | 01/01/2003 |
AHS Hospital Corp.
![]() AHS Hospital Corp. Hospital/Nursing ManagementHealth Services AHS Hospital Corp. provides prevention for the treatment of illness and the medical rehabilitation of people with physical disabilities. The company was founded in 1994 is headquartered in Montclair, NJ. | Corporate Officer/Principal | - |
Formazione di Janice M. Smiell
Drexel University College of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Aziende private | 4 |
---|---|
Alliqua BioMedical, Inc.
![]() Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | Health Technology |
LifeCell Corp.
![]() LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
AHS Hospital Corp.
![]() AHS Hospital Corp. Hospital/Nursing ManagementHealth Services AHS Hospital Corp. provides prevention for the treatment of illness and the medical rehabilitation of people with physical disabilities. The company was founded in 1994 is headquartered in Montclair, NJ. | Health Services |
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Janice M. Smiell